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RNA 30-phosphate cyclase (RtcA) synthesizes RNA
20,30 cyclic phosphate ends via three steps: reaction
with ATP to form a covalent RtcA-AMP intermediate;
transfer of adenylate to an RNA 30-phosphate to form
RNA(30)pp(50)A; and attack of the vicinal O20 on the
30-phosphorus to form a 20,30 cyclic phosphate.
Here we report the 1.7 A˚ crystal structure of the
RtcA-AMP intermediate, which reveals the mecha-
nism of nucleotidyl transfer. Adenylate is linked via
a phosphoamide bond to the His309 N3 atom.
A network of hydrogen bonds to the ribose O20 and
O30 accounts for the stringent ribonucleotide pre-
ference. Adenine is sandwiched in a hydrophobic
pocket between Tyr284 and Pro131 and the prefer-
ence for adenine is enforced by Phe135, which packs
against the purine C2 edge. Two sulfates bound near
the adenylate plausibly mimic the 30-terminal and
penultimate phosphates of RNA. The structure illumi-
nates how the four a2/b4 domains contribute to
substrate binding and catalysis.
INTRODUCTION
RNA 20,30 cyclic phosphate ends play important roles in RNA
metabolism, especially as intermediates in tRNA splicing and
repair (Konarska et al., 1982; Greer et al., 1983; Filipowicz and
Shatkin, 1983; Laski et al., 1983; Amitsur et al., 1987; Zillmann
et al., 1991; Zofallova et al., 2000; Nandakumar et al., 2008).
There are two enzymatic routes to generate RNA 20,30 cyclic
phosphate termini. The first is via transesterification, wherein
an internal ribose 20-OH attacks the adjacent 30-50 phospho-
diester and expels a 50-OH terminated RNA leaving strand
(Raines, 1998). The second pathway entails de novo cyclization
of an RNA 30-phosphomonoester in a three-step reaction that
consumes ATP (Filipowicz et al., 1983).
The RNA 30-terminal phosphate cyclase (Rtc) enzymes that
catalyze de novo cyclization comprise an enzyme family with
members distributed widely among bacterial, archaeal, and
eukaryal taxa (Genschik et al., 1997). Cyclization occurs via
a series of three nucleotidyl transfer reactions (Filipowicz et al.,
1985; Reinberg et al., 1985). In the first step, Rtc reacts withStructure 18,ATP and a divalent cation to form a covalent Rtc-AMP interme-
diate and liberate PPi. The AMP is linked via a P–N bond to an
invariant histidine side chain of Rtc. In the second step, the
adenylate is transferred from Rtc-AMP to the RNA 30-phosphate
terminus to form an activated phosphoanhydride intermediate,
RNA(30)pp(50)A. In the third step, the terminal ribose 20-OH
attacks the 30-phosphate of RNA(30)pp(50)A to generate an RNA
20,30 cyclic phosphate product and release AMP.
The crystal structure of the apoenzyme of E. coliRtcA revealed
a fold composed of four tandem modules, each comprising
a four-stranded b sheet overlying two a helices (Palm et al.,
2000). The essential His309 nucleophile is located within the
C-terminal module (Billy et al., 1999). Though lacking any bound
substrates or cofactors, the apoRtcA crystal structure contained
a citrate anion docked in the N-terminal module via electrostatic
and hydrogen bonding interactions with conserved amino acid
side chains, including three arginines that are essential for the
RNA cyclase and adenylyltransferase activities of the human
homolog Rtc1 (Tanaka and Shuman, 2009).
The distinctive 30 end-modification pathway of the Rtc
enzymes and the prominence of cyclic ends in RNA repair reac-
tions prompted our interest in extending the structural and
mechanistic framework developed by Filipowicz and colleagues
(Billy et al., 1999; Palm et al., 2000). Here we present the 1.7 A˚
crystal structure of the covalent RtcA-adenylate intermediate,
and a structure-guided mutational analysis, which provide new
insights to the mechanism of nucleotidyl transfer, the determi-
nants of nucleotide substrate specificity, and the distinctive
contributions of the four domain modules to formation of the
active site.RESULTS AND DISCUSSION
Crystallization and Structure Determination
Recombinant E. coli RtcA was produced as an N-terminal
His10-tagged fusion protein and purified from a soluble bacterial
extract by sequential Ni-agarose, anion exchange, and gel
filtration chromatography steps. Adenylyltransferase assays,
entailing incubation of 2 mM RtcA with 50 mM [a32P]ATP and
magnesium, elicited scant label transfer to the RtcA polypeptide,
to an extent that only 2% of the input RtcA was adenylylated
in vitro. The low yield of RtcA-[32P]AMP in vitro could reflect
a high extent of covalent adenylylation of RtcA during its produc-
tion in vivo, in which case the activity might be unmasked by
inclusion of pyrophosphate in the reaction mixtures, to promote449–457, April 14, 2010 ª2010 Elsevier Ltd All rights reserved 449
Table 1. E. coli RtcA Crystallographic Data and Refinement Statistics
Crystal dimensions @ 130 K P21 a = 83.73 A˚ b = 81.93 A˚ c = 105.18 A˚ b = 103.4

Radiation source NSLS-X29 l = 1.1 A˚
Crystallographic Data Quality (SCALEPACK)
Resolution A˚ 40.0 – 1.68 (1.70 – 1.68)
Rsym (for I > -sI) 7.3% (51.1%)
Unique reflectionsa 154840 (5035)
Mean redundancy 6.07 (4.1)
Completeness 98.5% (96.7%)
Mean I/sI 26.8 (2.1)
Molecular Replacement Statistics (PHASER)
MR scoringb RFZ = 8.0, 8.0, 5.5, 6.3 TFZ = 4.8,11.7,14.6,17.0 LLG = 93, 290, 461, 588
Refinement Statistics (PHENIX)
Resolution A˚ 35.13 – 1.68 (1.74 - 1.68)
R-factors (free/work) 0.207 / 0.168 (0.259 / 0.216)
Estimated coordinate error 0.22 A˚
Model Statistics
Model contents 1351 amino acids from 4 RtcA monomers 74 alternate conformations 8 sulfate, 10 glycerol,
5 sodium ions 1508 water molecules 5 residue peptide (chain E – His-tag)
RMS deviation for bonds / angles 0.012 A˚ / 1.46
Ramachandran outliers None
B-factors (A˚2): Wilson / Overall By chain
(A, B, C, D) Heteroatoms / Water
23.3 / 32.1 27.5, 28.9, 31.6, 33.0 59.3 / 42.3
Mean atomic anisotropyc 0.4 A˚
NCS deviationsd (A˚) (Ca residues 4-339) B C D
A 0.76 0.26 0.60
B 0.72 0.65
C 0.65
Standard definitions are used for all of the parameters. Figures in parentheses refer to data in the highest resolution bin.
a F+ and F- were treated as equivalent observations throughout scaling.
bMR statistics are the Z-scores for rotation (RFZ) and translation (TFZ) and the log-likelihood gain (LLG) following optimization of each of the fourmono-
mers of the search model.
c Anisotropy values are derived from TLS refinement.
d No NCS restraints were used during refinement.
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RNA 30-Phosphate Cyclasedeadenylylation by reversal of step1 of the cyclase pathway.
Indeed, we observed that 100 mM PPi elicited a >10-fold gain
of in vitro adenylylation, to an extent of 23% of the input RtcA
protomers. These findings suggested that the recombinant
RtcA was predominantly RtcA-AMP. To convert any residual
active apoenzyme to RtcA-AMP prior to crystallization, we incu-
bated a concentrated RtcA preparation with magnesium and
ATP and then isolated the protein by gel filtration. RtcA crystals
that grew in buffer containing ammonium sulfate and PEG(5000)-
monomethyl ether were in space group P21 and diffracted to
better than 1.7 A˚ resolution. Phases were obtained by molecular
replacement with apoRtcA. The structure was ultimately refined
at 1.68 A˚ resolution with R/Rfree values of 0.168/0.207 and excel-
lent geometry (Table 1). The crystals contained four RtcA proto-
mers in the asymmetric unit.
The omit density maps of all four protomers revealed the pres-
ence of AMP covalently linked via a P–N bond to His309. Figure 1
shows the density map of the histidinyl-AMP adduct and several
surrounding amino acids in protomer A. Thus, the structure
captures the RtcA-AMP catalytic intermediate in the RNA cycli-450 Structure 18, 449–457, April 14, 2010 ª2010 Elsevier Ltd All righzation pathway. There was little variability among the four RtcA
polypeptides (Table 1). A least-squares superposition of all four
RtcA protomers showed close alignment of the histidinyl-AMP
and vicinal amino acid side chains (see Figure S1 available
online). Henceforth, our discussion of the RtcA-AMP structure
will refer to the A protomer.
Comparision of RtcA-AMP and ApoRtcA
The fold of the RtcA-AMP intermediate is depicted in Figure 2A
with the four component domain modules colored as follows:
N-terminal domain 1 in magenta (amino acids [aa] 4-85), domain
2 in yellow (aa 86-177), domain 3 in blue (aa 186-277), and
domain 4 in green (aa 178-185 plus 278-339). Domains 1, 2
and 4 comprise a single globular unit with pseudo-three-fold
symmetry, into which domain 3 is inserted. Domain 3 packs
against domain 2 and forms a ‘‘lid’’ over the purine base of
AMP (Figure 2A). Superposition of RtcA-AMP on apoRtcA (from
Protein Data Bank [PDB] code 1QMH, colored gray in Figure 2A)
highlighted key differences in the two crystal structures. For
example, apoRtcA crystallized as a disulfide-linked homodimerts reserved
Figure 1. Covalent Linkage of AMP to
His309 N3
Stereo view of a finely sampled 1.7 A˚ composite
omit density map of the RtcA active site contoured
at 1.3 s (blue mesh; grid spacing 0.2 A˚). The red
mesh is the Fo-Fc difference density for the bound
adenylate contoured at 3.5 s. See also Figure S1
for a superposition of the active sites of the four
RtcA protomers in the asymmetric unit.
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RNA 30-Phosphate Cyclase(Palm et al., 2000). The covalent bond between the Cys308 side
chains of adjacent apoRtcA protomers is denoted by the arrow-
head in Figure 2A. By contrast, RtcA-AMP crystallized as a
monomer and the shortest distance betweenCys308 side chains
of neighboring protomers was 41 A˚ (not shown). Thus, E. coli
RtcA is not an obligate homodimer.
Whereas the b sheet scaffolds of the four domains are virtually
identical in apoRtcA and RtcA-AMP, there were local variations
elsewhere in main-chain conformation (reflected in phi/psi angle
changes) and substantial movements of a helices and connect-
ing loops (reflected in Ca position changes) in the transition from
apoenzyme to enzyme-adenylate (Figure 2B). Thesemovements
were centered principally around the AMP-binding site – entail-
ing shifts in several a helices of domains 2 and 4 plus a large
movement (3.8 A˚) in a domain 2 loop (aa 129-131)—and served,
together with side-chain conformational changes, to open up an
otherwise obstructed active site (discussed below). Domain 1
also experienced a significant structural change focused on an
oxyanion binding pocket, occupied by a citrate anion in apoRtcA
and by two sulfate anions in RtcA-AMP (Figure 2A). The proximity
of the sulfates to the covalent adenylate suggests that they plau-
sibly mimic either the phosphates of the PPi leaving group during
the RtcA adenylylation step or the terminal and penultimate RNA
phosphates during the RNA adenylylation step.
Chemical Linkage of AMP to Histidine
Protein phosphohistidine intermediates and products are
encountered inmany instances of enzymatic phosphoryl transfer
other than RNA cyclization. There appears to be no strict rule
as to which histidine nitrogen atom serves as the nucleophile.
For example, nucleoside diphosphate kinase forms a histidinyl-
Nd-phosphate intermediate during phosphoryl transfer to an
NDP phosphoacceptor (More´ra et al., 1995; Xu et al., 1997).
By contrast, succinyl-CoA-synthetase forms a histidinyl-N3-
phosphate intermediate, also during phosphoryl transfer to an
NDPphosphoacceptor (Fraser et al., 1999, 2000).Covalent catal-
ysis via histidine also applies to diverse nucleotidyl transfer reac-
tions, exemplified by galactose-1-phosphate uridylyltransferase
(GalT), which acts via an enzyme-UMP intermediate wherein
the UMP phosphorus is linked to histidine-N3 in the active site
(Wedekind et al., 1996). GalT belongs to the histidine-triadStructure 18, 449–457, April 14, 2010(HIT) family of nucleotidyl hydrolases and
transferases. Other members of the HIT
family that utilize adenosine nucleotide
substrates have been cocrystallized as
transition state mimetics with adenosine
and tungstate, wherein the tungstenatom is covalently linked to histidine-N3 in the active site (Lima
et al., 1997).
In the case of RNA cyclase, Billy et al. (1999) employed differ-
ential proteolysis andmass spectrometry to assignHis309 as the
site of covalent adenylylation in RtcA. However, their analysis did
not discriminate whether the P–N bondwas to histidine Nd or N3.
The RtcA-AMP structure resolves this issue, insofar as the omit
density map shows unambiguously that AMP is linked via a P–
N bond to the N3 atom of His309 (Figure 1). Despite a shared
use of histidine N3 as the attacking nucleophile, there is no struc-
tural similarity between RtcA and the HIT protein family; their
active sites are entirely different.
Architecture of the Adenylate-Binding Pocket
The adenosine nucleoside is bound to RtcA in an anti conforma-
tion with the adenine base buried in a hydrophobic pocket
(Figure 1). The adenine is sandwiched between Tyr284 on one
side, with which it forms a p stack, and Pro131 and Phe251 on
the other, with which it makes van der Waals contacts (Figures
1 and 3). Phe135 forms the back end of the adenine pocket
and the planar aromatic ring is oriented orthogonal to the edge
of the purine ring. The adenine C2 atom is pointed directly at
Phe135 at a distance of 3.6 A˚ from the plane of the phenyl ring
(Figure 1). The close van der Waals contacts of adenine C2
and Phe135 side chain (conserved as a tyrosine in hRtc1)
explains the strong preference of RtcA and hRtc1 for ATP versus
GTP as the substrate for enzyme-adenylylation and RNA cycliza-
tion (Genschik et al., 1997, 1998; Vicente and Filipowicz, 1988),
i.e., because the exocyclic 2-amino group of GTP would clash
sterically with Phe135.
There are no direct polar contacts between the adenine base
and RtcA amino acids. Rather, the polar edge of the adenine is
decorated with a network of interacting waters that bridge to
main-chain and side-chain atoms of RtcA, especially those in
domain 4 (Figure 3). Water-mediated contacts between adenine
N1 and N6 atoms and the Glu270 side chain, the Phe251 amide
and carbonyl, and the Arg249 carbonyl—though not adenine-
specific—could explain why RtcA is purine specific (Genschik
et al., 1998).
The ribose moiety of histidinyl-AMP adopts a C(20)-endo
conformation (Figure 1), which is stabilized by five hydrogenª2010 Elsevier Ltd All rights reserved 451
Figure 2. Comparison of the RtcA-AMP and
ApoRtcA Structures
(A) The A protomer of RtcA-AMP is superimposed
on the RtcA apoenzyme (the B protomer from
the 2.1 A˚ structure in PDB 1QMH). The four
domains of RtcA-AMP are colored as follows:
N-terminal domain 1 in magenta (amino acids
[aa] 4–85), domain 2 in yellow (aa 86–177), domain
3 in blue (aa 186–277), and domain 4 in green
(aa 178–185 plus 278–339). The AMP bound
covalently to His309 is depicted as a stick model
with green carbons. Two sulfate anions bound
to domain 1 are depicted as stick models. The
apoRtcA is colored gray. A citrate anion bound
to domain 1 of apoRtcA is shown as a stick model
with gray carbons. ApoRtcA crystallized as a
disulfide-linked homodimer; the disulfide crosslink
(denoted by the arrowhead) is shown between
Cys308 in the B protomer and Cys308 in the
equivalent a helix (in orange) of the apoRtcA A
protomer.
(B) Differences in main-chain Ca positions (A˚) and
conformation (phi and psi angles) of the superim-
posed RtcA-AMP and apoRtcA structures are
plotted for each amino acid in the primary struc-
ture. The margins of the four domain modules
are indicated above the x axis.
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RNA 30-Phosphate Cyclasebonds to the ribose O20 and O30 atoms (Figure 3). Asp287
accepts bidentate hydrogen bonds to its carboxylate oxygens
from the ribose 20-OH and 30-OH groups (Figure 1). The 30-OH
receives additional H-bonds from Gln104 N3 and from a water
coordinated by Gln18, Asn313 and Asp287 (Figure 3). The ribose
20-OH receives a hydrogen bond from the Gln288 N3 atom
(Figure 3). We speculate that these ribose contacts fix the posi-
tion of the nucleoside and thereby the orientation of the ATP
a-phosphate with respect to the His309 nucleophile. The exis-
tence of two dedicated hydrogen bonds to the ribose 20-OH
provides a rationale for the inability of RtcA (and hRtc1) to use
dATP as a substrate (Reinberg et al., 1985; Vicente and Filipo-
wicz, 1988; Genschik et al., 1997, 1998).
A striking feature of the RtcA-AMP structure is the absence
of direct contacts between protein functional groups and the
AMP phosphate oxygens (Figure 3). Assuming that histidine
adenylylation is catalyzed via an associative mechanism, we
expect an extra negative charge to develop on the ATP a-phos-
phate in the transition state. Most phosphoryl transferases
promote catalysis, at least in part, by neutralizing this negative
charge, typically via coordination of the nonbridging phosphate
oxygens by arginines and lysines and/or reliance on a divalent
cation cofactor that interacts with the reactive phosphate. In
RtcA-AMP the nonbridging oxygens are each coordinated by452 Structure 18, 449–457, April 14, 2010 ª2010 Elsevier Ltd All rights reservedawater molecule that bridges to an amino
acid side chain (Figure 3). Whereas the
Ser129-bridged water contact to the
AMP phosphate is not observed in all
four RtcA protomers; the Glu14-bridged
water contact is conserved. RNA cyclase
is strictly dependent on a divalent cation
for RNA cyclization and for enzyme-adenylylation (Genschik et al., 1998; Reinberg et al., 1985;
Filipowicz and Vicente, 1990). We propose that Glu14 comprises
part of the metal-coordination complex, and that the metal is
situated near the position of the water shown in Figure 3, where
it can coordinate the ATP a-phosphate (and, perhaps, the PPi
leaving group as well).
Another notable aspect of the RtcA active site is the absence
of direct protein interactions with the His309 Nd atom. Other
histidine-based covalent phosphoryl/nucleotidyl transferases
typically rely on hydrogen bond donation from the protonated
‘‘nonnucleophile’’ histidine nitrogen atom to a main-chain
carbonyl (in the case of GalT and other HIT proteins) or a side-
chain carboxylate (in nucleoside diphosphate kinase and
succinyl-CoA-synthetase) (Wedekind et al., 1996; Lima et al.,
1997; More´ra et al., 1995; Fraser et al., 1999). These contacts
are thought to assist in orienting the histidine for its attack on
the phosphorus center and in stabilizing the imidazolium group
in the covalent intermediate (Wedekind et al., 1996). In RtcA-
AMP, the His309 Nd interacts with a water molecule that is in
turn coordinated by Thr312 Og (Figure 3A), suggesting that
hydrogen bonding to the bridging water serves in lieu of the
orienting histidine-protein contacts seen in other transferases.
Human Rtc1 also has a threonine in the position equivalent to
RtcA Thr312.
Figure 3. The RctA Active Site
Stereo view of the active site in the A promoter of
RtcA-AMP. The folds of the four domains are
colored as in Figure 2. Selected amino acid side
chains and main-chain atoms, the covalently
boundadenylate, and the twosulfate anionsbound
to domain 1 are rendered as stick models. Waters
are depicted as red spheres. Hydrogen bonds are
indicated by black dashed lines; van der Waals
contacts are denoted by magenta dashed lines.
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RNA 30-Phosphate CyclaseActive Site Remodeling Precedes Adenylylation
The positions and orientations of many of the amino acid side
chains that bind AMP in the RtcA-AMP intermediate differ
substantially from their conformations in the apoRtcA structure.
In particular, Tyr284, which stacks on the AMP adenine, adopts
a different rotamer in apoRtcA so that the phenol ring overlaps
the AMP adenosine in the RtcA-AMP intermediate (Figure 2A).
Pro131 in apoRtcA also intrudes on the space occupied
by adenine in the RtcA-AMP intermediate. Consequently, the
AMP binding site is effectively occluded in the apoenzyme.
The superposition of the two structures indicates that the
‘‘closed’’ active site seen in apoRtcA transits to an ‘‘open’’
conformation by: (i) reorientation of Tyr284; (ii) a 3.8 A˚ movement
of the domain 2 loop that includes Pro131; and (iii) unkinking
of the domain 2 helix that includes Phe135 (Figure 2A). Key
residues in domain 4 also undergo conformation switches.
Asp287, which coordinates the ribose hydroxyls in RtcA-AMP,
is pointed in the opposite direction in the apoRtcA structure
(Figure 2A). The His309 nucleophile is out of position by 2.5 A˚
in the apoenzyme and is not properly oriented with respect to
the AMP phosphate (Figure 2A). AMP binding elicits an inward
movement of the proximal end of the His309-containing domain
4 helix and the preceding loop, which is necessarily coupled
to reorientation of Asp287 (which would sterically prevent the
helix movement if it remained in its apoenzyme rotamer). Finally,
the domain 1 loop between b1 and a1 undergoes a significant
rearrangement in RtcA-AMP versus apoRtcA in which the
Glu14 Ca shifts by 5.4 A˚ (Figures 2A and 2B). In apoRtcA, both
of the Glu14 carboxylate oxygens are hydrogen-bonded to the
Gly16 main-chain amide. In RtcA-AMP, these contacts are
severed, the loop moves, the proximal end of the a1 helix is
unwound (Figure 2A), and Glu14 makes new hydrogen bonds
to the Gln18 main-chain amide and to the phosphate-bridging
water discussed above.
Structure-Guided Mutagenesis of the
Adenylate-Binding Pocket
Nine residues identified presently as constituents of the AMP
binding site were targeted for mutational analysis. Gln104,
Ser129, Phe135, Phe251, Glu270, Tyr284, Asp297, and Gln288
were replaced individually by alanine and Pro131 was changedStructure 18, 449–457, April 14, 2010to glycine. To sample the extreme case
of complete loss of function, we also
mutated theHis309 nucleophile to alanine
and glycine. The RtcA mutants were pro-
duced in E. coli as His10 fusions and puri-
fied from soluble lysates by Ni-agaroseand anion exchange chromatography steps in parallel with
wild-type RtcA (Figure 4A).
To assay RNA cyclization, we used a 12-mer RNA 30-phos-
phate substrate labeled with 32P at the penultimate phosphate
(50-AAAAUAAAAGC*pCp). Wild-type RtcA and the RtcAmutants
(5 nM each) were reacted with 20 nM RNA, 100 mM ATP, and
10 mM MgCl2. Note that the ATP concentration used was
5-fold higher than the Km value of 20 mM ATP for the cyclase
reaction of E. coli RtcA (Genschik et al., 1998). The products
were digested with nuclease P1 and the labeled *pC (derived
from substrate) and the cyclized *pC > p product were resolved
by PEI-cellulose thin-layer chromatography (TLC). Whereas
wild-type RtcA cyclized 95% of the input RNA, the H309A and
H309G mutants were inert, as expected (Figure 4B). Q104A,
S129A, and E270A were as active or nearly as active as wild-
type RtcA in RNA cyclization (Figure 4B). We surmise that the
water-mediated contact of Ser129 with the AMP phosphate,
the hydrogen bond of Gln104 to the ribose O30, and the water-
mediated contact of Glu270 to adenine N6 are not essential for
RtcA catalysis. These inferences were underscored by assays
of RtcA adenylylation in the presence of PPi (Figure 4C), wherein
the Q104A and S129A proteins retained wild-type activity and
E270A yielded half as much enzyme-adenylate as wild-type
RtcA. In the case of Gln104 and Glu270, it is likely that their
contacts with the AMP ribose and adenine, respectively, are
functionally redundant with the other RtcA main-chain or side-
chain contacts to the same adenylate atoms (Figure 3).
The instructive findings were that Asp287 and Gln288, which
coordinate the ribose hydroxyls, were both essential for RtcA
activity. D287A and Q288A cyclized just 1% and 2% of the input
RNA (Figure 4B) and were virtually inert in RtcA adenylylation
(Figure 4C). There was a hierarchy of mutational effects at the
four hydrophobic residues that comprise the adenine pocket.
F135A was the most deleterious (3% cyclization), followed by
Y284A (12% cyclization), F251A (28% cyclization), and P131G
(33% cyclization) (Figure 4B). The yields of RtcA-[32P]AMP
in vitro by F135A, Y284A, F251A, and P131G were 2%, 2%,
38%, and 13% of the wild-type value, respectively (Figure 4C).
These results implicate Tyr284 and Phe135, which respectively
stack parallel and orthogonal to the purine ring, as the most
important constituents of the adenine pocket. Our mutationalª2010 Elsevier Ltd All rights reserved 453
Figure 4. Effects of Mutations in the AMP-Binding Pocket on Rtc1
Cyclase Activity
(A) Rtc1 purification. Aliquots (4 mg) of recombinant wild-type (WT) RtcA and
the indicated mutants were analyzed by SDS-PAGE. The Coomassie blue-
stained gel is shown. The positions and sizes (kDa) of marker polypeptides
are indicated on the left.
(B) Cyclase activity. Reaction mixtures (10 ml) containing 50 mM Tris-HCl
(pH7.4), 2mMDTT,10mMMgCl2, 100mMATP,20nM5
0-AAAAUAAAAGC*pCp
(a 12-mer RNA 30-phosphate substrate labeled with 32P at the penultimate
phosphate, prepared according to Tanaka and Shuman, 2009), and 5 nM
wild-type or mutant RtcA were incubated for 10 min at 37C. The mixtures
were adjusted to 50 mM sodium acetate (pH 5.2), 1 mM ZnCl2, and then
digested with nuclease P1 (1 U) at 50C for 10 min. The digests were analyzed
by ascending polyethyleneimine cellulose TLC with a buffer consisting of
4 M ammonium sulfate, 3 M sodium acetate, isopropanol (80:18:2, v:v:v).
The 32P-labeled nucleotides *pC (derived form the input RNA substrate) and
*pC > p (derived from the cyclized RNA product) were visualized and quantified
by scanning the TLC plate with a Fuji Film BAS-2500 imager. The extents of
RNA cyclization by the WT and mutant RtcA proteins are plotted. Each datum
is the average of three experiments and standard error of the mean (± SEM).
(C) RtcA adenylylation. Reaction mixtures (10 ml) containing 50 mM Tris-HCl
(pH 7.4), 10 mM MgCl2, 1 mM DTT, 50 mM [a
32P]ATP, 100 mM pyrophosphate
and 2 mM RtcA as specified were incubated at 37C for 10 min. The reactions
were quenched by adding 10 ml of 100mM Tris-HCl (pH 6.8), 200mMDTT, 4%
SDS, 20% glycerol, 40 mM EDTA, 0.2% bromophenol blue. The samples were
analyzed by electrophoresis through a 12% polyacrylamide gel containing
0.1% SDS. The RctA-[32P]AMP adducts were visualized by autoradiography
of the dried gels and quantified by scanning the gels with a Fuji BAS-2500
imager. The extents of adenylylation by the WT and mutant RtcA proteins
are plotted. Each datum is the average of three experiments ± SEM.
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454 Structure 18, 449–457, April 14, 2010 ª2010 Elsevier Ltd All righresults here for E. coli RtcA agree with the more limited muta-
tional analysis of two of the adenosine-binding residues in
human Rtc1, in which alanine changes at Tyr294 (equivalent to
RtcA Tyr284) and Asp297 (equivalent to RtcA Asp287) abolished
the cyclization and adenylyltransferase activities (Tanaka and
Shuman, 2009).
An Oxyanion-Binding Pocket in RtcA Domain 1
The A and C protomers of RtcA-AMP both contained two sulfate
anions bound to domain 1, at sites closely flanking the citrate
anion that was bound to the RtcA apoenzyme (Figure 2A).
The B and D protomers contained only one sulfate bound to
domain 1. The ‘‘invariant’’ sulfate occupies an oxyanion hole at
the proximal end of the a1 helix that was unwound in the transi-
tion from apoenzyme to enzyme-adenylate, wherein the sulfate
receives one direct and two water-mediated hydrogen bonds
from the main-chain amides of Glu14, Gly16, and Gly17, respec-
tively (Figure 3). The sulfate also forms a bidentate salt bridge to
Arg43 (Figure 3). Arg43 is conserved in humanRtc1 and essential
for its RNA cyclase and adenylyltransferase activities (Tanaka
and Shuman, 2009). The sulfate anion is situated 7 A˚ from the
AMP phosphate. We envision that this sulfate mimics the
30-phosphate of the RNA substrate and/or the phosphate in
the PPi leaving group derived from the ATP g-phosphate. The
distance between this sulfate/phosphate site and the AMPphos-
phate would presumably shorten in the presence of a bridging
divalent cation that counteracts the anionic charge repulsion.
Arg21 is poised to assist in coordinating the RNA 30-phosphate
during this approach to the histidinyl-adenylate and/or in coordi-
nating the ATP b phosphate during the adenylylation step. Arg21ts reserved
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Figure 5. Proposed Mechanism of RtcA Adenylation
The crystal structure and mutational effects suggest a model whereby nucle-
ophilic attack of the His309 N3 on the ATP a-phosphorus is facilitated by:
Structure
RNA 30-Phosphate Cyclaseis conserved in human Rtc1 and is essential for cyclase and
adenylyltransferase activities (Tanaka and Shuman, 2009).
The second sulfate anion in protomers A and C is poised on
the surface of domain 1, where it is coordinated by hydrogen
bonds from Gln51 N3 and His52 N3 (Figure 3). The first and
second sulfates are 6.5 A˚ apart (S to S distance), which mimics
the separation between adjacent phosphates (P to P) in a polynu-
cleotide. Thus, we speculate that the second phosphate marks
the position of the penultimate phosphate of the RNA substrate.
The first and second sulfates are bridged by a water molecule
coordinated by Arg40 (Figure 3). Arg40 is conserved in human
Rtc1 and essential for cyclase and adenylyltransferase activities
(Tanaka and Shuman, 2009). We propose that it, along with
Arg43, binds to the ATP g phosphate and RNA 30-phosphate
during the first and second nucleotidyl transfer steps of the
cyclase pathway. By contrast, although Gln51 and His52 are
also conserved in human Rtc1, neither residue is essential.
Changing Gln51 to alanine had no apparent effect on Rtc1 cycli-
zation activity, whereas changing His52 to alanine elicited a
2-fold reduction (Tanaka and Shuman, 2009); these findings
are consistent with a noncatalytic role for the contacts seen
here with the second sulfate anion.
(i) proper orientation of His309 via a water mediated hydrogen bond of Nd to
Thr312 Og; (ii) orientation of the adenylate by hydrogen bonding of the ribose
20 and 30 hydroxyls to Asp287 and Gln288; (iii) stabilization of the transition
state by a divalent cation (with imputed coordination of the metal by Glu14);
and (iv) orientation of the pyrophosphate leaving group apical to the attacking
His309 nucleophile via contacts of Arg21, Arg40, and Arg43with the ATP b and
g phosphates.Mechanistic Implications
The crystal structure of the enzyme-adenylate intermediate of
the RNA cyclase reaction pathway is, to our knowledge, the
second instance of an atomic structure of a nucleoside mono-
phosphate covalently linked to histidine in an enzyme active
site—the first being GalT linked to UMP (Wedekind et al.,
1996). As discussed above, the active site of RtcA-AMP is sui
generis and quite distinct from other histidine-based phos-
phoryl/nucleotidyl transferases. The present study extends initial
structural insights from the apoenzyme, which focused on the
novel arrangement of the four similarly folded domain modules.
We can now invoke a fairly clear division of labor among the
four structural modules, whereby: (i) essential side chains in
domains 2 and 4 comprise the adenosine binding pocket;
(ii) essential residues in domain 1 bind the PPi leaving group,
the RNA 30-terminal phosphates, and the metal cofactor; and
(iii) domain 3 forms a lid over the adenine pocket and makes
water-mediated purine-specific hydrogen bonds to N1 and N6.
Comparison of the apoRtcA and RtcA-AMP structures reveals
significant remodeling of the active site environment that must
precede or accompany the enzyme-adenylylation step.
Although there is clearly more to learn by capturing RtcA
structures in other states along the reaction pathway, the
available structural and mutational data for E. coli RtcA and
human Rtc1 prompt us to propose a catalytic mechanism for
the nucleophilic attack of His309 N3 on the ATP a-phosphorus
(Figure 5) driven by the following enzymic contributions to orien-
tation of the reactants and transition state stabilization: (i) orien-
tation of the histidine by water-mediated hydrogen bonding to
the nonnucleophilic Nd atom; (ii) positioning of the a-phosphorus
by tight constraints on the ribose conformation imposed by
Asp287, Gln288 and other contacts to the ribose hydroxyls;
(iii) orientation of the PPi leaving group apical to attacking
His309 achieved by ionic interactions of b and g phosphates
with the essential arginines of domain 1; and (iv) stabilizationStructure 18,of the transition state of the a-phosphate by a metal ion coordi-
nated by Glu14.EXPERIMENTAL PROCEDURES
E. coli RtcA Purification for Crystallization Experiments
The rtcA gene was amplified by polymerase chain reaction (PCR) from E. coli
genomic DNAwith primers designed to introduce a NdeI site at the ATG codon
for Met2 (amino acid sequence numbering according to Genschik et al., 1997)
and a BamHI site immediately downstream of the stop codon. The PCR
product was digested with NdeI and BamHI and then inserted between the
NdeI and BamHI sites of pET16b. The plasmid insert was sequenced
completely to exclude the acquisition of unwanted changes during amplifica-
tion and cloning. The pET-His10RtcA-(2-339) plasmid was transformed into
Escherichia coli BL21-Codon Plus (DE3) (Novagen).
To prepare RtcA for crystallization experiments, a 1 l culture derived from a
single transformant was grown at 37C in LB medium containing 100 mg/ml
ampicillin until the A600 reached 0.6 to 0.8. The culture was chilled on ice for
30 min and then adjusted to 0.1 mM isopropyl b-D-thiogalactoside and
2% (v/v) ethanol. Incubation was continued at 17C for 16 hr with constant
shaking. Cells were harvested by centrifugation and stored at 80C. All
subsequent procedureswere performed at 4C. The cell pellet was suspended
in 50 ml buffer A (50 mM Tris-HCl [pH 7.4], 250 mM NaCl, 10% sucrose) and
lysozyme was added to 0.2 mg/ml. After mixing gently for 30 min, the
suspensions were sonicated to reduce viscosity and insoluble material was
removed by centrifugation at 20,000 g for 30min. The soluble lysate wasmixed
for 1 hr with 6 ml of a 50% slurry of Ni-NTA agarose (QIAGEN) that had
been equilibrated in buffer A. The agarose was recovered by centrifugation
and resuspended in 10 ml buffer B (50 mM Tris-HCl [pH 7.4], 250 mM NaCl,
10% glycerol) containing 25 mM imidazole. The cycle of centrifugation and
resuspension of the agarose resin was repeated three times, after which the
washed agarose beads (3 ml) were poured into a column. Bound proteins
were eluted stepwise with 4 ml aliquots of 100, 200, 300, and 400 mM449–457, April 14, 2010 ª2010 Elsevier Ltd All rights reserved 455
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RNA 30-Phosphate Cyclaseimidazole in buffer B. The elution profile was monitored by SDS-PAGE.
His10RtcAwas recovered in the 200, 300 and 400mM imidazole eluates, which
were pooled and diluted with buffer C (50 mM Tris-HCl [pH 7.4], 10% glycerol)
to adjust the NaCl concentration to 100 mM. The protein solution was applied
to a 1ml column of DEAE-Sephacel equilibrated with 100mMNaCl in buffer C.
RtcA was recovered in the flow-through fraction (while residual nucleic acids
were bound to the DEAE resin). The DEAE flow-through preparation wasmixed
with solid ammonium sulfate to achieve 60% saturation. The protein precipi-
tate was collected by centrifugation and resuspended in 2 ml buffer D (10
mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol)
containing 2 mM ATP and 10 mM MgCl2. The protein sample was then gel-
filtered through a 120 ml 16/60 HiPrep Sephacryl S-100 HR column (GE
Healthcare) developed with buffer D at a flow rate of 1.0 ml/min. The peak
RtcA-containing fractions were pooled and concentrated by centrifugal ultra-
filtration.
Crystallization and Data Collection
Crystals of RtcA were grown by the hanging drop vapor diffusion method at
room temperature. The RtcA protein sample (8 mg/ml, in buffer D) was mixed
with an equal volume (2 ml) of the reservoir buffer containing 10 mM 2-(4-mor-
pholino)-ethane sulfonic acid (MES) (pH 6.5), 200 mM ammonium sulfate, and
20% (w/v) polyethyleneglycol-(5000)-monomethyl ether. Crystals grew to their
full size (400 3 150 3 50 mm) in 1 to 2 days. Single crystals were harvested,
cryoprotected by suspension in 10 mM MES (pH 6.5), 200 mM ammonium
sulfate, 25% polyethyleneglycol-(5000)-monomethyl ether, 7% glycerol, and
then flash frozen in liquid nitrogen. X-ray diffraction data were collected at
the National Synchrotron Light Source (Brookhaven, NY) beamline X29 (tuned
for maximum flux at 1.1 A˚ with a 100 mm beam aperture) equipped with an
ADSC-q315 CCD detector. A single crystal was used to collect a total of 432
frames of rotation data in three separate sweeps. The first sweep consisted
of 185 consecutive 1 oscillations and 1 s exposures. The second sweep
was designed to measure low-resolution reflections without generating over-
loaded pixels and was collected with a longer crystal-to-detector distance, a
10-fold attenuated beam, and 62 consecutive 3 oscillations. The third pass
was identical to the first but used 5 s exposures to capture weaker high-reso-
lution data. All data were processed using HKL2000 and SCALEPACK. The
diffraction statistics are compiled in Table 1.
Structure Determination and Refinement
RtcA crystallized in monoclinic space group P21 (a = 83.73 A˚, b = 81.93 A˚,
c = 105.18 A˚; a = g = 90.00 b = 103.44) with fourmonomers in the asymmetric
unit. Phases for RtcA were obtained via molecular replacement in PHASER
(McCoy et al., 2007) using the previously solved apoRtcA structure (Protein
Data Bank [PDB] code 1QMH) as a search model. Following map calculation
and initial model building in COOT (Emsley and Cowtan, 2004), the side chains
of the amino acids in the active site (and of those with unclear electron density)
were truncated to alanine and the resulting model was refined against the
crystallographic data in CNS (Brunger et al., 1998). Weighted difference
density maps generated from this initial refinement were used to model the
truncated side chains. A second round of refinement in CNS using a complete
protein model, but no AMP or solvent, revealed difference density for all
atoms in the covalent adenylate (as depicted in Figure 1 by the red mesh).
AMP was fit into the difference density map and refined using a combination
of standard stereochemistry and phosphoramidate bond distance and
angle target values derived from the geometry of the histidine-uridylate
observed in the structure of GalT (PDB 1HXQ) and the small-molecule struc-
ture of monosodium phosphoramidate (Hobbs et al., 1953). The model was
completed by adding heteroatoms and alternate amino acid conformations
as warranted by the difference density maps and then processed further in
PHENIX (Adams et al., 2002) via refinement of individual sites, simulated an-
nealing, TLS (translation/libration/screw) refinement, individual atomic
displacement parameters refinement, and occupancy refinement for alternate
conformations. The assignment of protein regions to TLS groups was per-
formed by the TLSMD server (Painter and Merritt, 2006). An additional round
of refinement using no bond or angle restraints about the tetrahedral phos-
phate atom revealed deviations from the stereochemically restrained refine-
ment of less than 0.05 A˚ for bonds and 2 for angles for all phosphorous
bonded atoms.456 Structure 18, 449–457, April 14, 2010 ª2010 Elsevier Ltd All righThe final refined model at 1.68 A˚ resolution (R/Rfree = 0.168/0.207)
included 1351 amino acids from the 4 RtcA monomers, with Ramachandran
values of 94.5% most favored, 5.5% allowed, and no residues with disal-
lowed conformations. The refinement statistics are compiled in Table 1.
The asymmetric unit of RtcA-AMP contains for monomers related by approx-
imate two-fold rotations giving rise to pseudo-orthorhombic non-crystallo-
graphic symmetry. Molecules A and B are related by a 180.9 rotation
about the (A X B) axis. Antiparallel main-chain hydrogen bonding between
residues 220 and 228 of each protomer resulted in an extended cross-
protomer eight-strand b sheet. A similar cross-protomer interaction is seen
between RtcA molecules C and D, which are themselves related by
a 183.5 rotation about the x axis, when crystallographic symmetry is applied
to the D protomer.
Mutational Analysis
Missense mutations were introduced into the rtcA-(2-339) ORF via the two-
stage PCR overlap extension method. The mutant rtcA genes were inserted
into pET16b. The plasmid inserts were sequenced completely to exclude
the acquisition of unwanted changes during amplification and cloning. The
pET-His10RtcA-(2-239) plasmids were transformed into Escherichia coli
BL21-Codon Plus (DE3). Wild-type and mutant His10RtcA proteins were
produced in parallel and purified from soluble bacterial lysates of 400-ml
bacterial cultures by procedures similar to those described above, except
for the following modifications: (i) 0.1% Triton X-100 was added to the cell
suspension during the lysis procedure; (ii) the Ni-agarose RtcA preparations
were dialyzed against buffer C containing 150 mM NaCl before passage
over 0.5 ml columns of DEAE-Sephacel to remove nucleic acids; (iii) the
ammonium sulfate precipitation and gel filtration steps were omitted. The
DEAE flow-through fractions of wild-type and mutant RtcA were stored
at 80C. Protein concentrations were determined by using the Bio-Rad
dye reagent with bovine serum albumin as the standard. The RtcA yields
from 400 ml cultures were between 8 and 30 mg protein.
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